New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
10:06 EDTCF, CELG, CBS, HAS, BAM, KO, TZOO, HRS, BMC, WFC, PGROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BMC Software (BMC) downgraded to Market Perform from Outperform at Raymond James... Brookfield (BAM) downgraded to Hold from Buy at Canaccord... Celgene (CELG) downgraded to Perform from Outperform at Oppenheimer... Harris (HRS) downgraded to Sell from Neutral at Lazard Capital... Hasbro (HAS) downgraded to Sell from Neutral at Goldman... Progressive (PGR) downgraded to Sell from Neutral at Citigroup... Travelzoo (TZOO) downgraded to Neutral from Buy at Ascendiant Capital... CBS (CBS) downgraded o Neutral from Overweight at Atlantic Equities... Wells Fargo (WFC) downgraded to Neutral from Market Perform at Leerink... Coca-Cola (KO) downgraded to Underperform from Outperform at CLSA... CF Industries (CF) downgraded to Hold from Buy at Dahlman Rose.
News For BMC;BAM;CELG;HRS;HAS;PGR;TZOO;CBS;WFC;KO;CF From The Last 14 Days
Check below for free stories on BMC;BAM;CELG;HRS;HAS;PGR;TZOO;CBS;WFC;KO;CF the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 11, 2014
09:03 EDTCELGCelgene shares can unlock big value, says RBC Capital
Subscribe for More Information
08:59 EDTTZOOTravelzoo Q1 outlook more uncertain after announcement, says Ascendiant
Ascendiant believes Travelzoo's announcement of new heads for its Search and Local businesses due to continued weakness in local voucher sales and lower search revenues adds uncertainty to its Q1 outlook. Ascendiant added that its checks indicate that Travelzoo’s Local Deals decreased 15% in Q1 and the firm maintains its Hold rating on the stock.
08:55 EDTTZOOTravelzoo makes management changes amid continued weakness in Local & Search
Subscribe for More Information
08:15 EDTWFCWells Fargo continues to expect future reserve releases
Subscribe for More Information
08:07 EDTWFCWells Fargo reports Q1 Basel III Advanced Tier 1 ratio 10.04%
Wells said capital continued to strengthen in the first quarter, with Common Equity Tier 1 of $132.7B under the Basel III General Approach, or 11.36% of risk-weighted assets. The Common Equity Tier 1 ratio under Basel III under the Advanced Approach, fully phased-in, was 10.04%.
08:04 EDTWFCWells Fargo reports Q1 provision for credit losses $325M
Reports net charge-offs of $825M, down $594M from first quarter 2013. Reports $500M reserve release due to continued strong credit performance and improved economic conditions. Chairman and CEO John Stumpf said, "First quarter 2014 earnings were another record for our Company and capital levels continued to strengthen. Returning more capital to our shareholders has remained a priority for Wells Fargo and we were pleased to have received a non-objection to our 2014 CCAR submission." CFO Tim Sloan said, “We are very pleased with Wells Fargo’s performance in the first quarter, particularly in some of the fundamental drivers of long term growth: loans, deposits, investments, capital and credit quality. Revenue remained relatively stable despite the impact of fewer days in the quarter, reflecting contributions from our diversified sources of fee revenue. In addition, we generated revenue more efficiently as we reduced expenses year-over-year and compared with fourth quarter of last year.”
08:01 EDTWFCWells Fargo reports Q1 EPS $1.05, consensus 97c
Subscribe for More Information
07:39 EDTKOCoca-Cola April volatility increases into Q1 and volume outlook
Subscribe for More Information
April 10, 2014
15:25 EDTWFCNotable companies reporting before tomorrow's open
Subscribe for More Information
13:07 EDTWFCWells Fargo April weekly 50 straddle priced for 2% move into Q1
12:36 EDTWFCEarnings Preview: Wells Fargo to report results after dividend hike
Wells Fargo (WFC), a bank holding company, is scheduled to report first quarter earnings before the open on Friday, April 11, with a conference call scheduled for 10:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of 97c on revenue of $20.6B, according to First Call. The consensus range for EPS is 90c-$1.02 on revenue of $19.5B-$22.41B. LAST QUARTER: Wells Fargo reported higher than expected Q4 EPS and revenue. The company said that it believes it can continue to grow its net interest margin over time. In a statement, CEO John Stumpf said, "Strong earnings power and capital levels, and an improving economic outlook are major reasons why we look ahead to 2014 with optimism." On March 26, Wells Fargo reported that the Federal Reserve had approved the bank’s capital allocation plan. Under the plan, Wells plans to pay a dividend of 35c per share. The dividend, which was increased 16.7% over prior levels, must be approved by the bank’s board of directors at its April 29 meeting. The bank also authorized the repurchase of an additional 350M shares of its own stock. STREET RESEARCH. In a note to investors on April 8, UBS wrote that Q1 may be the first quarter in four years that Wells Fargo’s EPS will not grow versus the previous quarter, as it believes the bank was hit with seasonal costs in Q1 that were not offset by revenue increases. The bank’s EPS will drop to 97c in Q1, down from $1.00 in Q4, but will still be up 5% versus the first quarter of 2013, the firm predicted. On a positive note, UBS contended that Wells Fargo was "a relative winner" of the Fed’s capital plan approval process. Although Wells' board has approved a 350M share increase in the bank’s stock repurchases, it typically doesn’t carry out large share repurchases, UBS stated. Wells should benefit from a continued U.S. economic recovery, but its shares already reflect such an outlook, according to UBS, which kept a Neutral rating on the stock. Meanwhile, Oppenheimer was somewhat upbeat about the sector's outlook. In a note to investors on April 3, the firm predicted that bank stocks would outperform the broader market by a few hundred basis points per year. Loan growth "remains sluggish," but reduced credit costs and expenses should enable banks to report results that show slight year-over-year improvements, the firm contended. PRICE ACTION: Wells’ stock is little changed over the last month, but is up 6% so far this year and nearly 29% over the last 12 months.
12:03 EDTCBSCBS says Stephen Colbert to be next 'Late Show' host
Subscribe for More Information
10:05 EDTCELGCelgene CEO Hugin says 'excited' about guidance for the year
Subscribe for More Information
10:00 EDTCFOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:10 EDTCELGCelgene likely to prevail in patent case, says Stifel
Subscribe for More Information
07:33 EDTCELGCelgene antibody could open door for new area of focus, says Wells Fargo
Wells Fargo believes that Celgene is developing an anti-CD47 antibody that could enable the company to enter the immune-oncology space and pivot into biologics. The firm views the stock as undervalued, and believes that Celgene has many viable opportunities that could enable the stock to rise over the long-term. The firm keeps an Outperform rating on the shares and identifies it as a top pick.
07:30 EDTWFCWells Fargo April volatility elevated at 20 into Q1 and outlook
Subscribe for More Information
06:35 EDTWFCMobile banking presents opportunity and risks for banks, WSJ reports
Subscribe for More Information
06:29 EDTKOCoca-Cola boosts advertising in repsonse to downward soda sales, WSJ says
Subscribe for More Information
06:20 EDTCFCF Industries downgraded to Equalweight from Overweight at Barclays
Barclays downgraded CF Industries based on relative valuation. Price target remains $267.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use